Palvella Therapeutics, Inc. (PVLA)
150.68
-3.64
(-2.36%)
USD |
NASDAQ |
Sep 18, 16:00
150.68
0.00 (0.00%)
After-Hours: 20:00
Palvella Therapeutics Total Assets (Quarterly) : 253.51M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 253.51M |
| March 31, 2026 | 263.76M |
| December 31, 2025 | 59.56M |
| September 30, 2025 | 66.94M |
| June 30, 2025 | 73.75M |
| March 31, 2025 | 79.44M |
| September 30, 2024 | 20.52M |
| June 30, 2024 | 25.05M |
| March 31, 2024 | 29.50M |
| December 31, 2023 | 38.68M |
| September 30, 2023 | 59.38M |
| June 30, 2023 | 87.54M |
| March 31, 2023 | 82.26M |
| December 31, 2022 | 95.49M |
| September 30, 2022 | 99.16M |
| June 30, 2022 | 114.31M |
| March 31, 2022 | 137.12M |
| December 31, 2021 | 153.56M |
| September 30, 2021 | 166.00M |
| June 30, 2021 | 155.03M |
| March 31, 2021 | 115.79M |
| December 31, 2020 | 105.01M |
| September 30, 2020 | 115.72M |
| June 30, 2020 | 117.78M |
| March 31, 2020 | 123.77M |
| Date | Value |
|---|---|
| December 31, 2019 | 141.10M |
| September 30, 2019 | 116.75M |
| June 30, 2019 | 130.84M |
| March 31, 2019 | 131.05M |
| December 31, 2018 | 141.34M |
| September 30, 2018 | 151.66M |
| June 30, 2018 | 162.02M |
| March 31, 2018 | 173.24M |
| December 31, 2017 | 103.88M |
| September 30, 2017 | 98.86M |
| June 30, 2017 | 105.96M |
| March 31, 2017 | 61.88M |
| December 31, 2016 | 35.06M |
| September 30, 2016 | 43.71M |
| June 30, 2016 | 46.45M |
| March 31, 2016 | 37.21M |
| December 31, 2015 | 33.95M |
| September 30, 2015 | 36.20M |
| June 30, 2015 | 14.48M |
| March 31, 2015 | 16.77M |
| December 31, 2014 | 21.88M |
| September 30, 2014 | 3.755M |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 7.399M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.64M |
| Shareholders Equity (Quarterly) | 216.87M |
| Debt to Equity Ratio | 0.1044 |
| Current Ratio | 21.18 |
| Net Debt Paydown Yield | -0.21% |